AdvaMed CEO appeals to US Senate for medtech tariff exemption
The request comes at a time when the medtech industry is facing tariff-induced headwinds of up to $500m in 2025. The post AdvaMed CEO appeals to US Senate for medtech tariff exemption appeared first on Medical Device Network.

The post AdvaMed CEO appeals to US Senate for medtech tariff exemption appeared first on Medical Device Network.